What is the recommended dose of Cetirizine (antihistamine) for infants under 1 year of age?

Cetirizine Dosing for Infants

Cetirizine is not recommended for infants under 6 months of age, but for infants 6-11 months old, the recommended dose is 0.25 mg/kg twice daily (approximately 2.25 mg twice daily for an average infant), administered as oral drops for precise weight-based dosing. 1, 2, 3

Age-Specific Dosing Guidelines

Infants Under 6 Months

• Cetirizine should not be used in infants under 6 months of age according to British guidelines, which emphasize consulting product labeling for age restrictions in this population 1
• The critical distinction between 5 months and 6 months is clinically significant, with guidelines specifically recommending against use below 6 months 1
• For infants under 6 months with allergic symptoms, non-pharmacologic measures such as allergen avoidance and supportive care should be prioritized instead 1

Infants 6-11 Months (Evidence-Based Dosing)

• The established safe and effective dose is 0.25 mg/kg administered twice daily (mean daily dose approximately 4.5 mg total) 3
• Use oral drops formulation for accurate weight-based dosing in this age group, as this allows precise measurement 4, 2
• This dosing was validated in the first randomized, double-blind, placebo-controlled study of any H1-antihistamine in infants, demonstrating safety comparable to placebo 3

Safety Profile in Infants 6-11 Months

The safety evidence for this age group is robust:

• No cardiac effects were observed, with no prolongation of QTc interval compared to baseline or placebo 3
• Sedation rates were actually lower than placebo in the pivotal infant study, with a trend toward fewer sleep-related disturbances in the cetirizine group 3
• The overall adverse event profile was indistinguishable from placebo, with no treatment-related safety concerns 3
• Long-term safety (up to 18 months) has been documented in children 12-24 months old, showing no developmental, neurologic, or cardiovascular concerns 5

Critical Safety Considerations

Renal Function

• Dose reduction is mandatory in moderate renal impairment (creatinine clearance 10-50 mL/min): reduce to half the standard dose 4, 2
• Avoid cetirizine entirely in severe renal impairment (creatinine clearance <10 mL/min) due to predominantly renal excretion 1, 4
• Routine renal function testing is not required in healthy infants for short-term use 1

Drug Interactions

• Do not combine with other sedating medications without considering additive CNS effects, as approximately 13.7% of patients experience sedation compared to 6.3% with placebo 4, 2
• First-generation antihistamines should be avoided entirely in this age group due to sedation risks and lack of safety data 1

Administration Timing and Practical Considerations

• Rapid onset of action occurs within 20 minutes of oral administration, with effects persisting for 24 hours 6
• Evening dosing may be preferable if any drowsiness occurs, though this is uncommon in infants 4
• The twice-daily dosing regimen (rather than once-daily) is specific to the infant age group and should not be altered 3

Common Pitfalls to Avoid

• Never assume all "second-generation" antihistamines are equally safe in infants - cetirizine has specific age-appropriate safety data that other agents may lack 1
• Avoid OTC cough and cold medications containing antihistamines in this age group due to toxicity concerns and lack of efficacy 1
• Do not use cetirizine in infants under 6 months, even at reduced doses, as safety has not been established 1
• Monitor infants with low body mass more carefully for sedation, even though rates are generally low 2